In 2014, the European Medicines Agency approved the drug Tecfidera for the treatment of relapsing multiple sclerosis, a neurodegenerative disease that affects millions of people worldwide. In multiple ...
Recently discovered electrophilic probes open the door to activity-based protein profiling (ABPP) studies of a broader range of proteins. It can be extremely challenging to study enzymes. Without any ...
New electrophilic reagents for activity-based protein profiling (ABPP) can discriminate between nucleophilic amino acids, such as cysteine, that are in different protein microenvironments. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback